SCHEMBL7423544

SCHEMBL7423544

CC(=O)Oc1ccc(C=Cc2cccc(O)c2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.66
▸ TTR P02766 2/20 0.66
▸ KDM4E B2RXH2 1/20 0.66
▸ MEN1 O00255 1/20 0.66
▸ LMNA P02545 1/20 0.66
▸ TP53 P04637 1/20 0.66
▸ MAPT P10636 1/20 0.66
▸ KMT2A Q03164 1/20 0.66
▸ SMN1; SMN2 Q16637 1/20 0.66
▸ TUBB4A P04350 2/20 0.56
▸ TUBB P07437 2/20 0.56
▸ TUBA3C P0DPH7 2/20 0.56
▸ TUBA1B P68363 2/20 0.56
▸ TUBA4A P68366 2/20 0.56
▸ TUBB4B P68371 2/20 0.56
▸ TUBB3 Q13509 2/20 0.56
▸ TUBB2A Q13885 2/20 0.56
▸ TUBB8 Q3ZCM7 2/20 0.56
▸ TUBA3E Q6PEY2 2/20 0.56
▸ TUBA1A Q71U36 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10943198 0.92 LMNA (0.72) CYP3A4TTRKDM4EMEN1LMNA
SCHEMBL719415 0.89 KMT2A (0.73) CYP3A4TTRKDM4EMEN1LMNA
SCHEMBL719416 0.89 KMT2A (0.73) CYP3A4TTRKDM4EMEN1LMNA
SCHEMBL18130117 0.86 CYP3A4 (0.60) CYP3A4TTRKDM4EMEN1LMNA
SCHEMBL18130118 0.86 CYP3A4 (0.60) CYP3A4TTRKDM4EMEN1LMNA
SCHEMBL2574064 0.85 LMNA (0.77) CYP3A4TTRKDM4EMEN1LMNA
SCHEMBL2574065 0.85 LMNA (0.77) CYP3A4TTRKDM4EMEN1LMNA
SCHEMBL716756 0.84 KMT2A (0.71) CYP3A4TTRKDM4EMEN1LMNA
SCHEMBL716755 0.84 KMT2A (0.71) CYP3A4TTRKDM4EMEN1LMNA
SCHEMBL10941162 0.84 MAPT (0.81) CYP3A4TTRKDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001060774-A1 SYNTHESIS OF RESVERATROL BRIGHAM YOUNG UNIVERSITY (US) 2001-08-23 — — WO disclosed
Send feedback